Chrysalis Biomedical Advisors

Chrysalis Biomedical Advisors is a private life science and healthcare strategy consulting firm serving startups, established companies, and investors. The firm focuses on commercial strategy, product evaluation, technology assessment, market intelligence, and go-to-market planning across diagnostics, therapeutics, digital health, genomics, and precision health. Its team includes former industry executives with backgrounds in companies such as Illumina, QIAGEN, and Syapse, and the firm emphasizes hands-on support from opportunity assessment through launch planning. Chrysalis appears to operate as a service business rather than a therapeutic product developer, so it does not have a traditional drug pipeline.